Annual Gross Profit
$141.09 M
-$10.77 M-7.09%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual gross profit is $141.09 million, with the most recent change of -$10.77 million (-7.09%) on December 31, 2023.
- During the last 3 years, KPTI annual gross profit has risen by +$35.71 million (+33.89%).
- KPTI annual gross profit is now -31.65% below its all-time high of $206.42 million, reached on December 31, 2021.
Performance
KPTI Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$37.48 M
-$3.84 M-9.29%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly gross profit is $37.48 million, with the most recent change of -$3.84 million (-9.29%) on September 30, 2024.
- Over the past year, KPTI quarterly gross profit has dropped by -$3.84 million (-9.29%).
- KPTI quarterly gross profit is now -70.14% below its all-time high of $125.53 million, reached on December 31, 2021.
Performance
KPTI Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$142.28 M
+$2.38 M+1.70%
September 30, 2024
Summary
- As of February 8, 2025, KPTI TTM gross profit is $142.28 million, with the most recent change of +$2.38 million (+1.70%) on September 30, 2024.
- Over the past year, KPTI TTM gross profit has increased by +$2.38 million (+1.70%).
- KPTI TTM gross profit is now -42.54% below its all-time high of $247.61 million, reached on June 30, 2022.
Performance
KPTI TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
KPTI Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -9.3% | +1.7% |
| 3 y3 years | +33.9% | +1.0% | +23.8% |
| 5 y5 years | +365.1% | +208.9% | +269.7% |
KPTI Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.6% | at low | -70.1% | +20.1% | -42.5% | +5.4% |
| 5 y | 5-year | -31.6% | +266.6% | -70.1% | +124.4% | -42.5% | +269.7% |
| alltime | all time | -31.6% | +8690.7% | -70.1% | >+9999.0% | -42.5% | >+9999.0% |
Karyopharm Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $37.48 M(-9.3%) | $142.28 M(+1.7%) |
| Jun 2024 | - | $41.32 M(+32.4%) | $139.90 M(+3.7%) |
| Mar 2024 | - | $31.21 M(-3.2%) | $134.96 M(-4.3%) |
| Dec 2023 | $141.09 M(-7.1%) | $32.26 M(-8.1%) | $141.09 M(+0.4%) |
| Sep 2023 | - | $35.10 M(-3.5%) | $140.54 M(-0.0%) |
| Jun 2023 | - | $36.38 M(-2.6%) | $140.61 M(-1.6%) |
| Mar 2023 | - | $37.35 M(+17.8%) | $142.96 M(-5.9%) |
| Dec 2022 | $151.86 M(-26.4%) | $31.71 M(-9.8%) | $151.86 M(-38.2%) |
| Sep 2022 | - | $35.16 M(-9.2%) | $245.68 M(-0.8%) |
| Jun 2022 | - | $38.74 M(-16.2%) | $247.61 M(+7.5%) |
| Mar 2022 | - | $46.24 M(-63.2%) | $230.33 M(+11.6%) |
| Dec 2021 | $206.42 M | $125.53 M(+238.3%) | $206.42 M(+79.6%) |
| Sep 2021 | - | $37.10 M(+72.9%) | $114.94 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $21.46 M(-3.9%) | $98.73 M(-10.6%) |
| Mar 2021 | - | $22.33 M(-34.4%) | $110.39 M(+4.8%) |
| Dec 2020 | $105.38 M(+173.8%) | $34.05 M(+62.9%) | $105.38 M(+19.7%) |
| Sep 2020 | - | $20.89 M(-36.9%) | $88.03 M(+11.0%) |
| Jun 2020 | - | $33.12 M(+91.2%) | $79.28 M(+42.5%) |
| Mar 2020 | - | $17.32 M(+3.7%) | $55.65 M(+44.6%) |
| Dec 2019 | $38.49 M(+26.9%) | $16.70 M(+37.6%) | $38.49 M(+75.0%) |
| Sep 2019 | - | $12.14 M(+27.8%) | $21.99 M(+117.9%) |
| Jun 2019 | - | $9.49 M(+6024.5%) | $10.09 M(+1582.2%) |
| Mar 2019 | - | $155.00 K(-24.8%) | $600.00 K(+34.8%) |
| Dec 2018 | $30.34 M(+1790.1%) | $206.00 K(-13.8%) | $445.00 K(+86.2%) |
| Sep 2018 | - | $239.00 K | $239.00 K |
| Dec 2017 | $1.60 M | - | - |
FAQ
- What is Karyopharm Therapeutics annual gross profit?
- What is the all time high annual gross profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual gross profit year-on-year change?
- What is Karyopharm Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly gross profit year-on-year change?
- What is Karyopharm Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM gross profit year-on-year change?
What is Karyopharm Therapeutics annual gross profit?
The current annual gross profit of KPTI is $141.09 M
What is the all time high annual gross profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual gross profit is $206.42 M
What is Karyopharm Therapeutics annual gross profit year-on-year change?
Over the past year, KPTI annual gross profit has changed by -$10.77 M (-7.09%)
What is Karyopharm Therapeutics quarterly gross profit?
The current quarterly gross profit of KPTI is $37.48 M
What is the all time high quarterly gross profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly gross profit is $125.53 M
What is Karyopharm Therapeutics quarterly gross profit year-on-year change?
Over the past year, KPTI quarterly gross profit has changed by -$3.84 M (-9.29%)
What is Karyopharm Therapeutics TTM gross profit?
The current TTM gross profit of KPTI is $142.28 M
What is the all time high TTM gross profit for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM gross profit is $247.61 M
What is Karyopharm Therapeutics TTM gross profit year-on-year change?
Over the past year, KPTI TTM gross profit has changed by +$2.38 M (+1.70%)